✅ Key Benefits:
Treats unresectable or metastatic melanoma
Used in combination with nivolumab for enhanced results
Boosts immune response against non-small cell lung cancer (NSCLC)
Also approved for renal cell carcinoma (RCC) and colorectal cancer
Administered via intravenous infusion
🧪 Active Ingredient:
Ipilimumab 50mg per 10ml
💉 Dosage & Administration:
Administered by a healthcare provider via IV infusion
Usually given every 3 to 6 weeks, depending on the treatment plan
Dosing may vary depending on cancer type, weight, and other ongoing therapies
⚠️ Precautions:
Inform your doctor about any autoimmune diseases, organ transplants, or ongoing infections
Can cause immune-related side effects such as inflammation in organs like the lungs, liver, or intestines
Regular monitoring via blood tests is required during treatment
❄️ Storage:
Keep in a refrigerator (2°C – 8°C)
Do not freeze. Protect from light.
📦 Packaging:
1 Vial of 10ml (50mg Ipilimumab)
🔍 Frequently Asked Questions (FAQs)
❓ What is Yervoy used for?
Yervoy (Ipilimumab) is used to treat advanced-stage cancers, including melanoma, non-small cell lung cancer, renal cell carcinoma, and colorectal cancer. It helps the immune system identify and destroy cancer cells.
❓ How does Yervoy (Ipilimumab) work?
Yervoy blocks the CTLA-4 protein on T-cells, enhancing the immune system’s ability to attack cancerous cells. This immune checkpoint inhibition is a breakthrough method in cancer treatment.
❓ Is Yervoy used alone or with other drugs?
Yervoy can be used alone or in combination with nivolumab (Opdivo) for better treatment response, especially in melanoma and NSCLC cases.
❓ What are the side effects of Yervoy?
Common side effects include fatigue, diarrhea, rash, nausea, and itching. Serious side effects can involve inflammation of organs like the lungs, liver, and colon.
❓ Can Yervoy cure cancer?
Yervoy is not a cure, but it improves survival rates and disease control in many patients. It significantly extends progression-free survival in advanced cancers.
❓ Is Yervoy chemotherapy or immunotherapy?
Yervoy is immunotherapy, not chemotherapy. It empowers the immune system to fight cancer rather than directly killing cancer cells like chemo does.
💬 Final Thoughts:
Yervoy 50mg/10ml (Ipilimumab) is a revolutionary immunotherapy injection that plays a crucial role in modern cancer treatment protocols. Backed by clinical success and global approval, it’s an essential part of personalized cancer care. Always consult with your oncologist for the best dosage and treatment combinations.
